We propose and develop mean-variance-ratio (MVR) statistics for comparing the performance of prospects (e.g., investment portfolios, assets, etc.) after the effect of the background risk has been mitigated. We investigate the performance of the statistics in large and small samples and show that in the non-asymptotic framework, the MVR statistic produces a uniformly most powerful unbiased (UMPU) test. We discuss the applicability of the MVR test in the case of large samples and illustrate its superiority in the case of small samples by analyzing Korea and Singapore stock returns after the impact of the American stock returns (which we view as the background risk) has been deducted. We find, in particular, that when samples are small, the MVR statistic can detect differences in asset performances while the Sharpe ratio test, which is the mean-standard-deviation-ratio statistic, may not be able to do so.
No takes yet. Share an insight, caveat, or question.
Bai et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: